Antipsychotics

Alzheimer’s disease and dementia present profound challenges in cognitive and functional decline among the elderly. While not curative, antipsychotic medications are sometimes used to manage behavioral symptoms like agitation, aggression, and hallucinations that can arise in these conditions. However, their use in dementia care is controversial due to potential side effects, including increased risk of stroke, sedation, and accelerated cognitive decline. Non-pharmacological approaches such as structured routines, cognitive stimulation, and environmental modifications are preferred whenever possible. Careful consideration by healthcare providers is essential, weighing the risks and benefits to ensure the highest quality of life for patients while minimizing adverse effects. Ongoing research aims to refine treatment strategies, emphasizing personalized care approaches tailored to the unique needs and responses of individuals with Alzheimer’s disease and other forms of dementia.

Committee Members
Speaker at Alzheimer’s Disease, Dementia & Cognitive Disorders Conference 2027 - London Jacqueline

London Jacqueline

Paris Diderot University, France
Speaker at Alzheimer’s Disease, Dementia & Cognitive Disorders Conference 2027 - Jacqueline Tuppen

Jacqueline Tuppen

Cogs Club, United Kingdom
Speaker at Alzheimer’s Disease, Dementia & Cognitive Disorders Conference 2027 - Zhenhuan Liu

Zhenhuan Liu

Guangzhou University of Chinese Medicine, China

Submit your abstract Today

Whatsapp